Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
Titel:
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma
Auteur:
Ascierto, Paolo A. Dummer, Reinhard Gogas, Helen J. Flaherty, Keith T. Arance, Ana Mandala, Mario Liszkay, Gabriella Garbe, Claus Schadendorf, Dirk Krajsova, Ivana Gutzmer, Ralf de Groot, Jan Willem B. Loquai, Carmen Gollerkeri, Ashwin Pickard, Michael D. Robert, Caroline